First Trust Health Care AlphaDEX Fund
FXH
256 hedge funds and large institutions have $911M invested in First Trust Health Care AlphaDEX Fund in 2023 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 71 increasing their positions, 94 reducing their positions, and 19 closing their positions.
26% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 19
2% more capital invested
Capital invested by funds: $891M → $911M (+$19.8M)
0.72% more ownership
Funds ownership: 57.51% → 58.23% (+0.72%)
0% more funds holding
Funds holding: 255 → 256 (+1)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
24% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 94
56% less call options, than puts
Call options by funds: $1.98M | Put options by funds: $4.51M
Top Buyers
Top Sellers
FXH Hedge Fund Activity: Q2 2023 in Review
256 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in First Trust Health Care AlphaDEX Fund (FXH) for Q2 2023, worth a combined $911M — up 2.2% from $891M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new FXH positions and 19 closed out — a net gain of 5 holders — while 71 added to existing stakes and 94 trimmed.
The largest buyer was J. Arnold Wealth Management, adding an estimated $25.7M. The largest seller was LPL Financial, cutting an estimated $8.9M.
- 256 institutional investors held First Trust Health Care AlphaDEX Fund (FXH) as of Q2 2023, up from 255 in Q1 2023.
- Funds reported $911M of First Trust Health Care AlphaDEX Fund stock for Q2 2023, up 2.2% quarter-over-quarter.
- 24 funds opened new First Trust Health Care AlphaDEX Fund positions in Q2 2023 and 19 closed out, a net change of +5 holders.
- The largest First Trust Health Care AlphaDEX Fund buyer in Q2 2023 was J. Arnold Wealth Management, an estimated $25.7M added.
- The largest First Trust Health Care AlphaDEX Fund seller in Q2 2023 was LPL Financial, an estimated $8.9M sold.
Based on aggregated 13F filings for Q2 2023.